[Clinical and prognostic value of therapy with contemporary beta-adrenoblockers in patients after myocardial infarction].
Bichan
N A
NA
Bykova
E F
EF
Gorbatovskiĭ
Ia A
IaA
Pakhtusova
N I
NI
Mishchenko
E P
EP
Kotarova
L V
LV
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D001578:Benzopyrans / Q000627:therapeutic use*; D004562:Electrocardiography; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D000068577:Nebivolol; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D004983:Ethanolamines; D000068577:Nebivolol; D008790:Metoprolol